Introduction
Distal-less 3 (Dlx3) is a homeodomain-containing transcription factor that is involved in key developmental events in several tissues including placental morphogenesis in the mouse as well as expression of key endocrine products of the human and mouse placentas [1e5] . In general, Dlx3 plays a role in the differentiation of epithelial compartments such as skin. For example, ectopic expression of Dlx3 in the basal layer of mouse epidermis results in cessation of proliferation of basal cells and enhanced differentiation of keratinocytes [6] . Complete genetic loss of Dlx3 in mice results in mid-gestation lethality presumably due to inadequate placental development, suggesting an important role for this transcription factor at the maternal fetal interface [2] ; however, clearly delineated roles for Dlx3 within the trophoectoderm and epiblast in the Dlx3
À/À mouse model have not been established. In trophoblast cell culture models, Dlx3 is a required transcriptional regulator of the a subunit of chorionic gonadotropin (CG) [7] .
Immunohistochemical studies of human placental sections obtained at 8 weeks gestation suggest that Dlx3 is expressed in villous cyto-and syncytial trophoblasts at a time when CG biosynthesis is high [4, 7] . Recently, Murthi and colleagues reported that Dlx3 transcript levels increased coincident with in vitro differentiation of human villous cytotrophoblasts where differentiation was measured by increased expression of the b subunit of CG as well as 3b-hydroxysteroid dehydrogenase [8] . These studies support the conclusion that Dlx3 may be playing a role in the regulation of expression of a and b subunits of CG as well as steroid hormone biosynthesis in the human placenta. Pathological conditions such as intrauterine growth restriction (IUGR) and pre-eclampsia (PE) have been linked to failure in placental morphogenesis correlated with aberrant gene expression, abnormalities in proangiogenic growth factor production and secretion, endothelial cell dysfunction and improper placental vascularization; all of which can lead to reduced placental perfusion and elevated levels of reactive oxygen species (ROS) within the placenta [9e12] . Interestingly, the Dlx3 null mice display dysregulated vascularization within the placental labyrinth [2, 4] coincident with reduced expression and secretion of the proangiogenic placental growth factor (PGF), a direct target of Dlx3 action [13] . Notably in women, reduced PGF levels in maternal serum serve as a key biomarker of PE [10, 14] ; in addition, the BPH/5 mouse model of PE also displays altered labyrinth morphogenesis, reduced PGF expression and maternal vascular remodeling [15, 16] . Taken together, these studies suggest that reduced expression of Dlx3 may be associated with placental insufficiency due to inappropriate expansion of the labyrinth within an environment of a reduced angiogenic potential; however, since the Dlx3 null animal is embryonic lethal, little is known regarding the role of Dlx3 governing the feto-placental unit past E9.5. The present studies provide evidence that conditional loss of Dlx3 specifically within the epiblast (rather than within the trophectoderm and epiblast in the Dlx3 À/À model) results in viable albeit phenotypically abnormal mice. These data provide indirect support for the conclusion that loss of Dlx3 within the placenta in the Dlx3 À/À model is likely central to embryonic lethality. Loss of a single Dlx3 allele has marked effects on intrauterine fetal growth patterns coincident with elevated oxidative stress and vascular dysfunction in murine placentas. These Dlx3-dependent placental defects are rescued with oral administration of an antioxidant given prior to conception and throughout gestation providing evidence that Dlx3 may be playing a role in the adaptation of the murine placenta to oxidative stresses during gestation.
Materials and methods

Animals
All mice used in these studies were maintained and used in compliance with protocols approved by the Cornell University Institutional Animal Care and Use Committee. Dlx3 þ/À and Dlx3 floxed (designated Dlx3 fl ; 17) mice were a generous gift from Dr. Maria Morasso (NIAMS, NIH). Meox2 CreSor mice [18] were purchased from the Jackson Labs (Bar Harbor, ME). Genotyping for the Dlx3 À/fl alleles was carried out by PCR using previously described methods [2, 17] . The Meox2 CreSor allele was determined using a PCR strategy described by the Jackson Labs. All animals examined were litters derived from mating Dlx3 þ/À , Meox2 CreSor males to Dlx3 fl/fl females.
The Dlx3 À/fl , Meox2
CreSor animals provide the unique opportunity to examine loss of Dlx3 specifically within the epiblast of the developing animal while the trophectoderrm is spared this genetic excision due to the fact that Meox2 CreSor Cre recombinase expression is epiblast-specific. Dlx3 À/fl , Meox2 CreSor animals were subjected to a pathological assessment including gross and histological analyses of skin, teeth, reproductive organs, submandibular salivary glands, adrenals and bone. Initial studies examined fetal growth characteristics in Dlx3 þ/þ and Dlx3 þ/À animals.
Fetuses were weighed and photographed at E9.5, 10.5, 12.5, 15.5 and 18.5. Crown rump measurements of each animal were obtained from photographs using the ImageJ Analysis Software (NIH). In a subsequent study, the superoxide dismutase mimetic, Tempol (Sigma, St. Louis MO), was administered in the drinking water (2 mM) of the Dlx3 þ/þ and Dlx3 þ/À female mice as previously described [19] . Sterile drinking water was used as the control. All animals in this study were killed at E12.5.
Oxidative stress and Western Blot analyses of protein lysates
Placental disk samples from Dlx3 þ/þ and Dlx3 þ/À animals were collected at E10.5, 12.5, and 15.5. Protein complexes were resolved on SDS-polyacrylamide (10%) gel electrophoresis and transferred to polyvinylidine difluoride membranes. Some blots were assayed using the Oxidation Detection Kit, (OxyblotÔ; Millipore, Billerica, MA) as per the manufacturer's instructions. Actin levels (Santa Cruz Biotechnology, Santa Cruz CA) were determined as a lane loading control. Band intensity within the OxyBlots was determined using ImageJ Analysis Software (NIH) and standardized for the actin levels within each gestational age and plotted as relative fold change.
Other blots were probed with a Dlx3 and actin antibodies as described previously [4] . Relative density of each band was determined and standardized to actin levels.
Assessment of placental apoptosis
Placental tissues were collected from Dlx3 þ/þ and Dlx3 þ/À in the Tempol and normal water-treated groups at E12.5. Placental tissues were fixed in 10% formalin and paraffin embedded. Sections were cut at 10 mm and subjected to analyses using a terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) Apoptosis Detection kit (Millipore, Billerica, MA) according to manufacturer's instructions.
Stained sections were scanned and digitized using an Aperio Scanscope (Vista CA). Data are reported as number of TUNEL-positive cells/10Â field within the labyrinth and maternal decidua.
Assessment of placental labyrinth, artery and vein area
Some formalin-fixed sections were incubated with mouse anti-human smooth muscle actin (SMA) monoclonal antibody (1:50; DakoCytomation, Glostrup, Denmark) to examine maternal arteries and veins (n ¼ 6e8/animal/treatment group). Some sections were incubated with biotinylated GSL I-iso-lectin B4 (1:100, Vector Laboratories, Burlingame, CA) to delineate vasculature within the labyrinth. AEC (Invitrogen, Carlsbad, CA) was used as chromogen to visualize antigen localization, and the sections were lightly counterstained with hematoxylin and eosin (H&E). Stained sections were imaged on an Aperio Scanscope (Vista, CA). Sections representing the widest portion of the placental disk were evaluated. Full placental area and area of the labyrinth and total area and luminal area of maternal vessels were quantitated using Aperio software. Data are presented as area of the labyrinth as a proportion of the total placental area and luminal area of a vessel as a proportion of the total vessel area.
Statistical analysis
Data was analyzed using analysis of variance. Comparisons were made by Student's t-test. All data are expressed as means AE standard error of the mean. A p value of <0.05 was considered statistically significant.
Results
Mice with conditional epiblast-restricted deletion of the Dlx3 gene survive to weaning
Our initial studies examined the hypothesis that conditional deletion of Dlx3 within the epiblast and embryonic loss of Dlx3 would result in embryonic lethality consistent with the Dlx3 À/À mouse model. To examine this hypothesis, we bred Dlx3 À/fl animals expressing Cre recombinase in the epiblast using a Meox2
CreSor allele [18] . Surprisingly, Dlx3
CreSor animals survived to weaning and beyond at expected genetic ratios albeit with substantial phenotypic defects ( Fig. 1 and Table 1 ). Dlx3
CreSor mice were generally smaller than gender-matched littermate controls and grossly displayed abnormal hair growth patterns ( Fig. 1A and data not shown). Histological examination of several tissues revealed marked differences between the Dlx3 À/fl , Meox2 CreSor animals and their littermate controls consistent with the role of Dlx3 during development [3,6,20e22] . For example, the epidermis was characterized by 1e2 cells thick and hair follicles contain well-formed, pigmented hairs in wild type mice. In Dlx3 À/fl , Meox2 CreSor mice, the epidermis is up to 4 cells thick and follicles contain amorphous keratin (Fig. 1B) . In teeth, the dentin and enamel of the wild type mouse was homogenous and lined by a single layer of columnar odontoblasts and ameloblasts. In Dlx3 À/fl , Meox2 CreSor mice, the dentin was irregular and lined by an attenuated layer of odontoblasts. The enamel was lost during processing (Fig. 1B) . Bony trabecule in the bone of wild type mouse were composed of a small amount of remnant cartilage covered by a thick layer of osteoid, which often enveloped osteocytes. Plump osteoblasts lined the trabecule. In Dlx3
CreSor mice, bony trabecule were composed of thick cartilaginous cores covered by a thin layer of osteoid (Fig. 1B) . Altogether these results indicate the impact of loss of Dlx3 in the developing embryo was substantial in many tissues that have been shown to express Dlx3 as part of a developmental program [3, 17, 23, 24] . Moreover, this model provides support for the conclusion that sparing loss of Dlx3 within the trophoectoderm/ placenta results in Dlx3-deficient embryos reaching birth and beyond, providing indirect evidence that the placental lesions within the Dlx3 À/À feto-placental unit likely are an important contributor to embryonic lethality.
Dlx3 gene dosage affects fetal growth trajectory
Dlx3 À/À animals die at E9.5, which restricts assessment of the role of Dlx3 later in gestation [2, 4, 5] . To determine a role for Dlx3 later in gestation, we examined the impact of haploinsufficiency of Dlx3 on fetal growth and placental viability during gestation. We initially determined that Dlx3 þ/À did indeed express reduced levels of Dlx3 in the placenta at E12.5 (Fig. 2) . Once established, embryos from Dlx3 þ/À matings were weighed at embryonic days (E) 9.5, 10.5, 12.5, 15.5 and 18.5 and assigned to genotype. Fetal weights were similar at E9.5 and E10.5 in both genotypes. However, at E12.5 and 15.5, weight gain was delayed in Dlx3 þ/À fetuses compared to controls (Fig. 3A) . By E18.5, the fetal weights were indistinguishable between genotypes (data not shown). Since Dlx3 is expressed in both the embryo as well as the placental labyrinth, we next focused on the impact of loss of Dlx3 within the placental disk.
Loss of one Dlx3 allele results in elevated placental oxidative stress
Placental disks were collected from Dlx3 þ/þ and Dlx3 þ/À animals at 3 different gestational time points (E10.5, 12.5 and 15.5). Samples were assayed for changes in carbonylation of cellular protein, which serves as a marker of oxidative stress [25] . placentas were harvested at 3 different gestational time points, E10.5, 12.5, and 15.5 (n ¼ 3e4/group). Equal amounts of placental tissue lysates were subjected to an Oxyblot assay to determine the abundance of protein carbonyl side chains which are indicative of oxidative stress. Actin was used to standardize carbonyl staining. C. Using ImageJ software, intensity of specific protein carbonyl bands (<a>, and <c> in panel B) was determined and standardized to the actin bands. The data are expressed as relative fold change where the Dlx3 þ/þ observation within embryonic day is standardized to 1.0. * differs in pairwise comparison indicated, p < 0.05. at E12.5 (Fig. 4A) , fully 3 days beyond the normal timing of fetal demise of these animals [2] . It should be noted that Tempol had no effect on fetal growth in Dlx3 þ/þ mice.
Antioxidant therapy rescues the Dlx3
Increased TUNEL-positive cells were detected throughout the Dlx3 þ/À labyrinth compared to Dlx3 þ/þ animals receiving water ( Fig. 5A and B) . Interestingly, the effects of loss of Dlx3 within the labyrinth (the site of Dlx3 expression) were paralleled with elevated cell death within the maternal decidua in Dlx3 þ/À animals receiving water (Fig. 5C and D) suggesting possible paracrine communication between labyrinth trophoblasts and maternal decidua. In both compartments, administration of Tempol reduced the apoptotic index in the Dlx3 þ/À animals compared to water controls. One potential cause of elevated oxidative stress within the developing placenta is altered remodeling of placental vascularization leading to reduced placental perfusion. Morasso and colleagues [2] described a reduced and compacted labyrinth area with reduced fetal vasculature in the Dlx3 À/À placenta and increased density within the decidua. Based upon these observations, we assessed placental labyrinth area and cross-sectional area of maternal vasculature in the Dlx3 þ/À using histological techniques. For these studies, the labyrinth and vascular compartments were identified using H&E, iso-lectin staining and immunohistochemistry for SMA (Fig. 6) . Initially, we quantitated total placental and labyrinth area at the widest portion of the histological sections in the Dlx3 þ/þ and Dlx3 þ/À mice receiving water or
Tempol. Unlike the Dlx3 À/À placenta, total labyrinth area did not appear reduced or compacted in the Dlx3 þ/À and was unaffected by Tempol (Fig. 6A) . In contrast, maternal spiral artery luminal area was reduced in the Dlx3 þ/À mice compared to Dlx3 þ/þ mice receiving normal water ( Fig. 6B and C) , and this was normalized in Dlx3 þ/À mice receiving Tempol. Luminal area of maternal veins within these placentas were unaffected by genotype or antioxidant treatment (data not shown).
Discussion
Complete loss of Dlx3 in the developing placenta has a clear impact on placental morphogenesis as well as fetal fitness [2] . Our studies indicate conditional loss of Dlx3 within the epiblast of the developing embryo does not affect the ability of Dlx3 À/fl ,
Meox2
CreSor animals to survive the neonatal period and reach weaning ( Fig. 1A and Table 1 ); however, defects in skin, teeth and bone were observed in Dlx3 À/fl , Meox2
CreSor animals consistent with a role for Dlx3 in the development of these tissues [3, 17, 23, 24] . These results support two important conclusions: our genetic approach for epiblast-specific Dlx3 gene excision was effective in altering developmental outcomes in tissues known to be regulated by Dlx3 in the fetus and adult animal; and sparing Dlx3 gene excision from the trophectoderm cell lineage in this model resulted in a normal distribution of Dlx3-deficient animals reaching weaning suggesting that Dlx3-dependent effects within the trophoectoderm play a fundamental role in fetal survival of the Dlx3 À/À animal. Despite these findings, there are important limitations to this study that need to be considered carefully. Unlike the Dlx3 À/À animal, Meox2
CreSor animals do not display epiblastspecific Cre expression until w E6.0 [18] . Thus, key Dlx3-dependent developmental events may have occurred prior to gene excision in the Dlx3
CreSor embryo. Additionally, Cre is express widely within the Meox2 CreSor embryos; however, Cre expression is considered slightly mosaic [18] . Despite these caveats, the Dlx3 À/fl ,
CreSor animals display predictable phenotypes in skin, teeth and bone as have been previously described in patients with Dlx3 deficiencies and during mouse development in tissues that are known to express Dlx3 [2, 3, 28] . These studies indirectly support the conclusion that mid-gestational embryonic lethality associated with Dlx3 À/À mice is linked to placental lesions caused by loss of leaving open the possibility that other mechanisms governing fetal growth provide compensation for the loss of a Dlx3 allele; conversely, the role of Dlx3 in later gestation may shift in importance relative to late gestation fetal growth. Future studies will examine this issue. Oxidative stress induced by loss of Dlx3 is clearly causal relative to the cell death and retarded fetal growth phenotypes since oral administration of a potent antioxidant (Tempol) prior to conception and throughout gestation protected against these phenotypes (Figs. 4 and 5) . The use of Tempol in these studies was patterned after studies of oxidative stress in the BPH/5 model since key water intake and pharmacodynamic studies carefully defined the parameters of Tempol administration and uptake in mice [19] . In those studies, oral Tempol administration did not affect water intake in mice; and electron spin resonance spectrophometry demonstrated significant in vivo plasma levels of Tempol radicals suggesting this route of administration was appropriate and effective. What remains to be determined is if Dlx3 is playing a direct or indirect role (or both) in processes leading to oxidative stress in trophoblasts expressing Dlx3 and in extralabyrinth compartments within the feto-placental unit (such as within maternal decidua) that do not express Dlx3. Markers of oxidative stress in maternal blood and urine indicate that under normal circumstances, pregnancy is characterized by high oxidative stress largely due to the high metabolic demand by the placenta [29e31] coupled with reduced placental ROS scavenging potential [32] . Placental oxidative stress is further exacerbated in pregnancies complicated by PE, IUGR, and diabetes (reviewed in [33, 34] ). Although a precise mechanism(s) associated with increased placental ROS generation in at risk pregnancies has not been fully elucidated, one compelling hypothesis arises from observations of placental vasculature associated with PE. Pregnancies complicated by PE exhibit reduced remodeling of maternal spiral arteries [35] resulting in impaired placental perfusion leading to potential harmful effects on fetal growth kinetics [36] . A similar relationship has also been reported in the BPH/5 mouse where reduced angiogenic potential is associated with incomplete vascular remodeling [16] . Our own studies have demonstrated that Dlx3 has a direct effect on transcriptional regulation of the mouse PGF gene promoter and loss of Dlx3 results in reduced secretion of PGF in placental explants cultured in vitro [13] . VEGF and PGF are thought to be important biomarkers of PE [37, 38] . This putative loss of angiogenic potential may have a direct effect of vascular remodeling, effectively reducing or delaying the normal dilation of maternal spiral arteries and maintaining relatively high vascular resistance and impaired placental perfusion. This notion would be consistent with the role of PGF as a proangiogenic factor in modulating vascular remodeling in some tumor models [39] . Hedlund and colleagues showed that tumor-derived PGF appeared to contribute to increased microvessel organization, branching morphogenesis and diameter, including the ability of PGF to contribute to vascular remodeling in spontaneously arising human choriocarcinomas. These studies provide support the conclusion that loss of Dlx3-dependent PGF may be one causative factor in altered or delayed maternal vascular remodeling in the Dlx3 þ/À model system through paracrine actions of PGF on maternal vasculature. Therapeutic antioxidant treatments represent a potentially powerful defense from the ROS-mediated placental abnormalities during pregnancy. Supplementation of vitamin C and E during the second trimester of pregnancy in women decreased biochemical incidence of ROS [40] . Further, gestational supplementation of vitamins C and E indicate a significant reduction in syncytiotrophoblast apoptosis associated with placental hypoxia [41] . However, not all of the studies examining the utility of antioxidant supplementation during at risk pregnancies have resulted in positive effects (reviewed by [42] ). Critical timing of antioxidant therapy is essential to effectively reduce oxidative stress within the placenta. Inadequate supplementation during pregnancy could address some of the controversy in the therapeutic value of antioxidant therapy. Myatt and colleagues have indicated antioxidant therapy appears to be most effective when administered prior to conception and during early gestation [34] . The timing of Tempol administration in the present study is consistent with this recommendation. The present studies suggest that loss of full expression of Dlx3 and or Dlx3 target genes within placental trophoblasts is linked to accommodation or adaptation to oxidative stresses leading to loss of fetal well-being coincident with altered placental vasculature. This may be reinforced more directly by the anecdotal observation that Tempol therapy rescued a small number of Dlx3 null fetuses beyond their normal timeframe of demise supporting speculation that the loss of Dlx3 within the placenta and fetus is linked to mechanisms supporting the adaptation to oxidative stress. Antioxidant therapy prior to and during gestation ameliorates abnormal placental morphogenesis and placental angiogenesis induced by loss of Dlx3; the outcome of which clearly leads to improved fetal fitness.
In sum, the present studies support the conclusions that loss of a single Dlx3 allele results in abnormal levels of placental oxidative stress linked to elevated placental apoptosis and reduced or delayed fetal growth and maternal spiral artery remodeling. The effects of Dlx3 on trophoblast populations may include reduced expression of proangiogenic growth factors such as PGF that likely help explain effects of loss of Dlx3 in placental compartments distal to the labyrinth (the site of Dlx3 expression) such as within the maternal spiral arteries and decidua. Hence the impact of Dlx3 and the Dlx3 gene network on adaptation to oxidative stress within the feto-placental until may be more far-reaching than previously appreciated.
